• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有症状性低钠血症的治疗。

Treatment of symptomatic hyponatremia.

作者信息

Decaux Guy, Soupart Alain

机构信息

Hôpital Universitaire Erasme, Bruxelles, Belgium.

出版信息

Am J Med Sci. 2003 Jul;326(1):25-30. doi: 10.1097/00000441-200307000-00004.

DOI:10.1097/00000441-200307000-00004
PMID:12861122
Abstract

Inadequate treatment of severe hyponatremia (<120 mEq/L) can be associated with severe neurological damage. In acute (<48 hours) hyponatremia, usually observed in the postoperative period, prompt treatment with hypertonic saline (3%) can prevent seizures and respiratory arrest. For patients with chronic (>48-72 hours) symptomatic hyponatremia, correction must be rapid during the first few hours (to decrease brain edema) followed by a slow correction limited to 10 mmol/L over 24 hours to avoid the development of osmotic demyelinating syndrome. In patients with asymptomatic hyponatremia, slow correction is the appropriate approach. When patients are overtreated, neurologic damage can be prevented by relowering the serum sodium (SNa) so that the daily increase in SNa remains below 10 mmol/L/24 hours. Frequent measurements of SNa during the correction phase of SNa are mandatory to avoid overcorrection. The use of urea to treat hyponatremia represents an advantageous alternative to hypertonic saline.

摘要

严重低钠血症(<120 mEq/L)治疗不充分可能会导致严重的神经损伤。在急性(<48小时)低钠血症中,通常在术后出现,迅速用高渗盐水(3%)治疗可预防癫痫发作和呼吸骤停。对于慢性(>48 - 72小时)有症状的低钠血症患者,最初几个小时内必须快速纠正(以减轻脑水肿),随后在24小时内缓慢纠正,使血钠升高限制在10 mmol/L以内,以避免渗透性脱髓鞘综合征的发生。对于无症状的低钠血症患者,缓慢纠正是合适的方法。当患者治疗过度时,可通过再次降低血清钠(SNa)来预防神经损伤,使SNa每日升高幅度保持在<10 mmol/L/24小时。在SNa纠正阶段,必须频繁测量SNa以避免纠正过度。使用尿素治疗低钠血症是高渗盐水的一种有利替代方法。

相似文献

1
Treatment of symptomatic hyponatremia.有症状性低钠血症的治疗。
Am J Med Sci. 2003 Jul;326(1):25-30. doi: 10.1097/00000441-200307000-00004.
2
[Treatment of severe hyponatremia (<120mEq/l)].[严重低钠血症(<120mEq/L)的治疗]
Rev Med Brux. 2001 Oct;22(5):413-9.
3
Risk of Overcorrection in Rapid Intermittent Bolus vs Slow Continuous Infusion Therapies of Hypertonic Saline for Patients With Symptomatic Hyponatremia: The SALSA Randomized Clinical Trial.高渗盐水治疗症状性低钠血症患者的快速间歇性推注与缓慢连续输注治疗的矫枉过正风险:SALSA 随机临床试验。
JAMA Intern Med. 2021 Jan 1;181(1):81-92. doi: 10.1001/jamainternmed.2020.5519.
4
The treatment of hyponatremia.低钠血症的治疗。
Semin Nephrol. 2009 May;29(3):282-99. doi: 10.1016/j.semnephrol.2009.03.002.
5
Prevention of brain demyelination in rats after excessive correction of chronic hyponatremia by serum sodium lowering.通过降低血清钠过度纠正慢性低钠血症后大鼠脑脱髓鞘的预防
Kidney Int. 1994 Jan;45(1):193-200. doi: 10.1038/ki.1994.23.
6
Limits of brain tolerance to daily increments in serum sodium in chronically hyponatraemic rats treated with hypertonic saline or urea: advantages of urea.慢性低钠血症大鼠经高渗盐水或尿素治疗后大脑对血清钠每日增量的耐受性极限:尿素的优势
Clin Sci (Lond). 1991 Jan;80(1):77-84. doi: 10.1042/cs0800077.
7
Reinduction of hyponatremia improves survival in rats with myelinolysis-related neurologic symptoms.低钠血症的再次诱导可改善患有脱髓鞘相关神经症状大鼠的存活率。
J Neuropathol Exp Neurol. 1996 May;55(5):594-601. doi: 10.1097/00005072-199605000-00011.
8
Urea minimizes brain complications following rapid correction of chronic hyponatremia compared with vasopressin antagonist or hypertonic saline.与血管加压素拮抗剂或高渗盐水相比,尿素可最大程度减少慢性低钠血症快速纠正后的脑并发症。
Kidney Int. 2015 Feb;87(2):323-31. doi: 10.1038/ki.2014.273. Epub 2014 Aug 6.
9
Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.高渗盐水和去氨加压素:安全纠正严重低钠血症的简单策略。
Am J Kidney Dis. 2013 Apr;61(4):571-8. doi: 10.1053/j.ajkd.2012.11.032. Epub 2012 Dec 23.
10
Treatment of symptomatic hyponatremia with hypertonic saline: a real-life observational study.治疗症状性低钠血症的高渗盐水:一项真实世界观察性研究。
Eur J Endocrinol. 2021 May;184(5):647-655. doi: 10.1530/EJE-20-1207.

引用本文的文献

1
Predictive value of hyponatremia for short-term mortality in supratentorial spontaneous intracerebral hemorrhage: a single center study.幕上自发性脑出血患者低钠血症对短期死亡率的预测价值:一项单中心研究
Front Neurol. 2024 Jan 25;15:1301197. doi: 10.3389/fneur.2024.1301197. eCollection 2024.
2
Syndrome of inappropriate antidiuretic hormone secretion as a side effect of chemotherapy for testicular cancer: A case report.抗利尿激素分泌不当综合征作为睾丸癌化疗的副作用:一例报告。
IJU Case Rep. 2019 Oct 11;2(6):327-329. doi: 10.1002/iju5.12122. eCollection 2019 Nov.
3
Focus on neonatal and infantile onset of nephrogenic syndrome of inappropriate antidiuresis: 12 years later.
聚焦于肾源性尿崩症新生儿及婴儿期发病:12 年后。
Pediatr Nephrol. 2019 May;34(5):763-775. doi: 10.1007/s00467-018-3922-6. Epub 2018 Mar 15.
4
Impact of long-term potassium supplementation on thiazide diuretic-induced abnormalities of glucose and uric acid metabolisms.长期钾补充对噻嗪类利尿剂引起的葡萄糖和尿酸代谢异常的影响。
J Hum Hypertens. 2018 Apr;32(4):301-310. doi: 10.1038/s41371-018-0036-3. Epub 2018 Mar 1.
5
Current management of refractory ascites in patients with cirrhosis.肝硬化患者难治性腹水的当前管理。
J Int Med Res. 2018 Mar;46(3):1138-1145. doi: 10.1177/0300060517735231. Epub 2017 Dec 6.
6
Effects of Hyponatremia on the Brain.低钠血症对大脑的影响。
J Clin Med. 2014 Oct 28;3(4):1163-77. doi: 10.3390/jcm3041163.
7
The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials.血管加压素V2受体拮抗剂治疗肝硬化腹水患者:一项随机对照试验的荟萃分析。
BMC Gastroenterol. 2015 Jun 9;15:65. doi: 10.1186/s12876-015-0297-z.
8
Severe Hyponatremia due to Phlegmonous Trismus.因脓性牙关紧闭导致的严重低钠血症
Case Rep Dent. 2014;2014:320438. doi: 10.1155/2014/320438. Epub 2014 Dec 25.
9
Impact of perioperative hyponatremia in children: A narrative review.围手术期低钠血症对儿童的影响:一项叙述性综述。
World J Crit Care Med. 2014 Nov 4;3(4):95-101. doi: 10.5492/wjccm.v3.i4.95.
10
Acute symptomatic seizures and systemic illness.急性症状性癫痫发作与全身性疾病。
Continuum (Minneap Minn). 2014 Jun;20(3 Neurology of Systemic Disease):614-23. doi: 10.1212/01.CON.0000450969.61204.6f.